908 Devices (NASDAQ:MASS) Posts Earnings Results, Beats Estimates By $0.01 EPS

908 Devices (NASDAQ:MASS) issued its earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.01, Zacks reports. 908 Devices had a negative return on equity of 14.87% and a net margin of 34.68%.The company had revenue of $17.38 million during the quarter, compared to the consensus estimate of $16.19 million.

Here are the key takeaways from 908 Devices’ conference call:

• Q4 revenue from continuing operations was $17.4 million, up 21% year‑over‑year, driven by demand for XplorIR, initial VipIR shipments, and strong U.S. state & local adoption.
• The company achieved positive adjusted EBITDA of $0.7 million in Q4 (vs. a loss of $4.0M a year ago) after cost and manufacturing consolidation, and targets cutting the 2025 adjusted EBITDA loss roughly in half in 2026 to the mid‑single‑digit millions.
• Product momentum is accelerating — shipped more than 40 VipIR units in Q4 (~$3M revenue) and delivered over 150 quant‑enabled XplorIR units in 2025 (XplorIR +40% YoY); the next‑gen MX908 platform is planned for commercial launch in 2026.
• Financial position strengthened with $113 million in cash and no debt, giving flexibility to invest in growth and support programs like AVCAD, for which the company expects $2M–$3M of revenue in 2026.
• Despite quarterly improvement, full‑year 2025 reported a net loss from continuing operations of $33.3 million and an adjusted EBITDA loss of $9.6 million, driven largely by non‑cash goodwill impairment and contingent consideration valuation changes, indicating ongoing profitability risks.

908 Devices Stock Up 6.6%

Shares of 908 Devices stock opened at $6.74 on Thursday. 908 Devices has a 52 week low of $2.67 and a 52 week high of $9.34. The business has a 50 day moving average price of $6.18 and a 200-day moving average price of $6.64. The company has a market cap of $243.92 million, a PE ratio of 12.25 and a beta of 0.47.

Insider Activity

In related news, CFO Joseph H. Iv Griffith sold 23,175 shares of the company’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $6.18, for a total transaction of $143,221.50. Following the completion of the sale, the chief financial officer owned 139,896 shares in the company, valued at approximately $864,557.28. This represents a 14.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 23.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On 908 Devices

Hedge funds have recently bought and sold shares of the company. Millennium Management LLC raised its holdings in shares of 908 Devices by 409.0% in the fourth quarter. Millennium Management LLC now owns 158,103 shares of the company’s stock valued at $830,000 after purchasing an additional 127,040 shares during the last quarter. Engineers Gate Manager LP bought a new stake in 908 Devices in the 4th quarter worth about $140,000. Bridgeway Capital Management LLC increased its stake in 908 Devices by 65.6% in the 4th quarter. Bridgeway Capital Management LLC now owns 50,500 shares of the company’s stock valued at $265,000 after buying an additional 20,000 shares during the last quarter. First Light Asset Management LLC increased its stake in 908 Devices by 92.6% in the 4th quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company’s stock valued at $25,390,000 after buying an additional 2,325,690 shares during the last quarter. Finally, State of Wisconsin Investment Board bought a new position in shares of 908 Devices during the 4th quarter worth approximately $170,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of 908 Devices in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.00.

About 908 Devices

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.